Cargando…
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis
Histiocytic disorders are an exceptionally rare group of diseases with diverse manifestations and a paucity of approved treatments, thereby leading to various challenges in their diagnosis and management. With the discovery of novel molecular targets and the incorporation of targeted agents in the m...
Autores principales: | Salama, Hind Abdin, Jazieh, Abdul Rahman, Alhejazi, Ayman Yahya, Absi, Ahmed, Alshieban, Saeed, Alzahrani, Mohsen, Alaskar, Ahmed, Gmati, Giamal, Damlaj, Moussab, Abuelgasim, Khadega A., Alghamdi, Abdulrahman, Alahmari, Bader, Almugairi, Areej, Alzahrani, Hazza, Bazarbachi, Ali, Musa, M.O.H., Goyal, Gaurav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434330/ https://www.ncbi.nlm.nih.gov/pubmed/32943371 http://dx.doi.org/10.1016/j.clml.2020.08.007 |
Ejemplares similares
-
Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience
por: Abuelgasim, Khadega A., et al.
Publicado: (2021) -
Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review
por: Abuelgasim, Khadega A., et al.
Publicado: (2020) -
Reducing Central Venous Catheter Use in Peripheral Blood Stem Cell Donation: Quality Improvement Report
por: Ghazi, Samer, et al.
Publicado: (2017) -
Promising remissions in relapsed refractory classical Hodgkin lymphoma patients requiring multiple salvage regimens before transplantation in the brentuximab vedotin era
por: Abuelgasim, Khadega A, et al.
Publicado: (2021) -
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
por: Abuelgasim, Khadega A., et al.
Publicado: (2019)